切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2018, Vol. 08 ›› Issue (04) : 173 -177. doi: 10.3877/cma.j.issn.2095-2015.2018.04.008

所属专题: 文献

综述

腹泻型肠易激综合征与显微镜下结肠炎的诊治进展
李桂红1, 晏喻婷1, 蒋波涛1,()   
  1. 1. 400711 广州中医药大学附属重庆市北碚中医院消化科
  • 收稿日期:2018-01-04 出版日期:2018-08-01
  • 通信作者: 蒋波涛

Advances in diagnosis and treatment of diarrhea-predominant irritable bowel syndrome and microscopic colitis

Guihong Li1, Yuting Yan1, Botao Jiang1,()   

  1. 1. Department of Gastroenterology, Guangzhou University of Chinese Medicine Affiliated Chongqing Beibei Hospital of Traditional Chinese Medicine, Chongqing 400711, China
  • Received:2018-01-04 Published:2018-08-01
  • Corresponding author: Botao Jiang
  • About author:
    Corresponding author: Jiang Botao, Email:
引用本文:

李桂红, 晏喻婷, 蒋波涛. 腹泻型肠易激综合征与显微镜下结肠炎的诊治进展[J/OL]. 中华消化病与影像杂志(电子版), 2018, 08(04): 173-177.

Guihong Li, Yuting Yan, Botao Jiang. Advances in diagnosis and treatment of diarrhea-predominant irritable bowel syndrome and microscopic colitis[J/OL]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2018, 08(04): 173-177.

腹泻型肠易激综合征(diarrhea-predominant irritable bowel syndrome,IBS-D)与显微镜下结肠炎(microscopic colitis,MC)在临床表现上均为反复发作的、非出血性、水样或稀糊状腹泻,且结肠镜检查均为正常黏膜像,但二者却为不同性质的2种疾病。IBS-D的诊断是基于症状学基础的罗马Ⅲ标准,MC的确诊方法是结肠镜下结肠黏膜组织活检。由于IBS-D与MC在临床症状上的重叠和阴性结肠镜表现,极易造成二者之间的误诊。目前全球尚无统一的MC诊断共识,国内的临床医师对MC的认识不足、结肠镜下黏膜活检率低,造成MC临床极高的误诊率。本文从IBS-D和MC的流行病学、病因、临床症状、诊断、治疗,及其临床症状重叠情况的研究进展进行综述。

The diarrhea-predominant irritable bowel syndrome(IBS-D)and microscopic colitis(MC)are recurrent, non hemorrhagic, water or dilute diarrhea in the clinical manifestations, and the colonoscopy shows normal mucosa.But the two are two diseases of different nature.The diagnosis of IBS-D is based on the Rome Ⅲ standard based on symptomatology.The diagnostic method of MC is colonoscopic colonic mucosa biopsy.Because of the overlap of clinical symptoms and negative colonoscopy between IBS-D and MC, it is easy to cause misdiagnosis.At present, there is no unified consensus on MC diagnosis in the world.The lack of understanding of MC by clinicians in China and the low rate of mucosal biopsy under colonoscopy cause the high misdiagnosis rate of MC.This paper makes a review of the research progress of epidemiology, etiology, clinical symptoms, diagnosis, treatment and clinical symptoms overlap of IBS-D and MC.

1
Kamp EJCA, Kane JS, Ford AC.Irritable bowel syndrome and microscopic colitis: a systematic review and meat-analysis[J]. Clin Gastroenterol Hepatol, 2016, 14(5): 659-668.
2
Lovell RM, Ford AC.Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis[J]. Clin Gastroenterol Hepatol, 2012, 10(7): 712-721.
3
Sperber AD, Dumitrascu D, Fukudo S, et al.The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review[J]. Gut, 2017, 66(6): 1075-1082.
4
张璐,段丽萍,刘懿萱,等.中国人群肠易激综合征患病率和相关危险因素的Meta分析[J].中华内科杂志, 2014, 53(12): 969-975.
5
Zhao YF, Guo XJ, Zhang ZS, et al.Epidemiology of Functional Diarrhea and Comparison with Diarrhea-Predominant Irritable Bowel Syndrome: A Population-Based Survey in China[J]. PLoS One, 2012, 7 (8): 906-907.
6
Lindström CG.'Collagenous colitis’ with watery diarrhea-a new entity?[J]. Pathol Eur, 1976, 11(1): 87-89.
7
Lazenby AJ, Yardley JH, Giardiello FM, et al.Lymphocytic ( "microscopic" ) colitis: a comparative histopathologic study with particular reference to collagenous colitis[J]. Hum Pathol, 1989, 20(1): 18-28.
8
Johan Bohr, Anna wickbom, Agnes Hegedus, et al.Diagnosis and management of microscopic colitis: Current perspectives[J]. Clin Exp Gastroenterol, 2014, 21(7): 273-284.
9
Pardi DS, Tremaine WJ, Carrasco-Labra A. American Gastroenterological Association institute technical review on the medical management of microscopic colitis[J]. Gastroenterology, 2016, 150(1): 247-274.
10
Pardi DS.Diagnosis and Management of Microscopic Colitis[J]. Am J Gastroenterol, 2017, 112 (1): 78-85.
11
Williams JJ, Kaplan GG, Makhija S, et al.Microscopic colitis-defining incidence rates and risk factors: a population-based study[J]. Clin Gastroenterol Hepatol, 2008, 6(1): 35-40.
12
Tong J, Zheng Q, Zhang C, et al.Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis[J]. Am J Gastroenterol, 2015, 110(2): 265-276.
13
Gu HX, Zhi FC, Huang Y, et al.Microscopic colitis in patients with chronic diarrhea and normal colonoscopic findings in Southern China[J]. Int J Colorectal Dis, 2012, 27(9): 1167-1173.
14
汤辉,田久林,蒋波涛,等.显微镜结肠炎的诊疗进展[J].世界华人消化杂志, 2017, 25(14): 1272-1278.
15
Spiller R, Aziz Q, Creed F, et al.Guidelines on the irritable bowel syndrome: mechanisms and practical management[J]. Gut, 2007, 56(12): 1770-1798.
16
中华医学会消化病学分会胃肠功能性疾病协作组.中国肠易激综合征专家共识意见[J].中华消化杂志, 2016, 36 (5): 299-312.
17
Koskela RM, Karttunen TJ, Niemelä SE, et al.Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis[J]. Eur J Gastroenterol Hepatol, 2008, 20(4): 276-282.
18
Roth B, Gustafsson RJ, Ohlsson B. Auto-antibodies and their association with clinical findings in women diagnosed with microscopic colitis[J]. PLoS One, 2013, 8(6): e66088.
19
Beaugerie L, Pardi DS.Review article: drug-induced microscopic colitis-proposal for a scoring system and review of the literature[J]. Aliment Pharmacol Ther, 2005, 22(4): 277-284.
20
Fernández-Bañares F, de Sousa MR, Salas A, et al.Impact of current smoking on the clinical course of microscopic colitis[J]. Inflamm Bowel Dis, 2013, 19(7): 1470-1476.
21
Ung KA, Gillberg R, Kilander A, et al.Role of bile acids and bile acid binding agents in patients with collagenous colitis[J]. Gut, 2000, 46(2): 170-175.
22
Aigner T, Neureiter D, Müller S, et al.Extracellular matrix composition and gene expression in collagenous colitis[J]. Gastroenterology, 1997, 113(1): 136-143.
23
Helal TE, Ahm ed NS, El Fotoh OA.Lymphocytic colitis: a clue to bacterial etiology[J]. World J Gastroenterol, 2005, 11(46): 7266-7271.
24
Zhu L, Huang D, Shi L, et al.Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea[J]. Health Qual Life Outcomes, 2015, 13: 49.
25
Canavan C, Card T, West J, et al.The Incidence of Other Gastroenterological Disease following Diagnosis of Irritable Bowel Syndrome in the UK: A Cohort Study[J]. PLoS One, 2014, 9(9): e106478.
26
Longestreth GF, Yao JF.Irritable bowel syndrome and surgery: a multivariable analysis[J]. Gastroenterology, 2004, 126(7): 1665-1673.
27
Gentile N, Yen EF.Prevalence, Pathogenesis, Diagnosis, and Management of Microscopic Colitis[J]. Gut Liver, 2018, 12(3): 227-235.
28
Tontini GE, Pastorelli L, Spina L, et al.Microscopic colitis and colorectal neoplastic lesion rate in chronic nonbloody diarrhea: a prospective, multicenter study[J]. Inflamm Bowel Dis, 2014, 20(5): 882-891.
29
Storr MA.Microscopic colitis: epidemiology, pathophysiology, diagnosis and current managemen-an update 2013[J]. ISRN Gastroenterol, 2013, 2013: 352718.
30
Stoicescu A, Becheanu G, Dumbrava M, et al.Microscopic colitis-a missed diagnosis in diarrhea-predominant irritable bowel syndrome[J]. Mdica, 2012, 7 (1): 3-9.
31
Longstreth GF, Thompson WG, Chey WD, et al.Functional bowel disorders[J]. Gastroenterology, 2006, 130(5): 1480-1491.
32
Ford AC, Moayyedi P, Lacy BE, et al.American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation[J]. Am J Gastroenterol, 2014, 109 Suppl 1: S2-S26.
33
Münch A, Langner C. Microscopic colitis: clinical and pathologic perspectives[J]. Clin Gastroenterol Hepatol, 2015, 13(2): 228-236.
34
Weinberg DS, Smalley W, Heidelbaugh JJ, et al.American Gastroenterological Association Institute Guideline on the Pharmacological Management of Irritable Bowel Syndrome[J]. Gastroenterology, 2014, 147(5): 1146-1148.
35
Lembo AJ, Lacy BE, Zuckerman MJ, et al.Eluxadoline for irritable bowel syndrome with diarrhea[J]. N Engl J Med, 2016, 374(3): 242-253.
36
Nguyen GC, Smalley WE, Vege SS, Carrasco-Labra A, Clinical Guidelines Committee.American Gastroenterological Association Institute Guideline on the Medical Management of Microscopic Colitis[J]. Gastroenterology, 2016, 150(1): 242-246.
37
Münch A, Aust D, Bohr J, et al.Microscopic colitis: Current status, present and future challenges: statements of the European Microscopic Colitis Group[J]. J Crohns Colitis, 2012, 6(9): 932-945.
38
Bonderup OK, Hansen JB, Teglbjaerg PS, et al.Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial[J]. Gut, 2009, 58(1): 68-72.
39
Miehlke S, Madisch A, Kupcinskas L, et al.Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis[J]. Gastroenterology, 2014, 146(5): 1-2.
40
Gralnek IM, Hays RD, Kilbourne A, et al.The impact of irritable bowel syndrome on health-related quality of life[J]. Gastroenterology, 2000, 119(3): 654-660.
41
Ghoshal UC, Gwee KA, Chen M, et al.Development, translation and validation of enhanced Asian Rome Ⅲ questionnaires for diagnosis of functional bowel diseases in major asian languages: a Rome foundation Asian neurogastroenterology and motility association working team report[J]. J Neurogastroenterol Motil, 2015, 21(1): 83-92.
42
Hilpüsch F, Johnsen PH, Goll R, et al.Microscopic colitis: a missed diagnosis among patients with moderate to severe irritable bowel syndrome[J]. Scand J Gastroenterol, 2017, 52 (2): 173.
43
Guagnozzi D, Ariasá, Lucendo AJ.Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders[J]. Aliment Pharmacol Ther, 2016, 43 (8): 851-862.
44
Limsui D, Pardi DS, Camilleri M, et al.Symptomatic overlap between irritable bowel syndrome and microscopic colitis[J]. Inflamm Bowel Dis, 2010, 13(2): 175-181.
45
Macaigne G, Lahmek P, Locher C, et al.Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study[J]. Am J Gastroenterol, 2014, 109(9): 1461-1470.
46
Kane JS, Rotimi O, Everett SM, et al.Development and validation of a scoring system to identify patients with microscopic colitis[J]. Clin Gastroenterol Hepatol, 2015, 13(6): 1125-1131.
47
Olesen M, Eriksson S, Bohr J, et al.Microscopic colitis: a common diarrhoeal disease.An epidemiological study in Orebro, Sweden, 1993-1998[J]. Gut, 2004, 53(3): 346-350.
48
Jessurun J, Yardley JH, Lee EL, et al.Microscopic and collagenous colitis: di?erent names for the same condition?[J]. Gastroenterology, 1986, 91(6): 1583-1584.
49
Pokorny CS, Kneale KL, Henderson CJ.Progression of collagenous colitis to ulcerative colitis[J]. J Clin Gastroenterol, 2001, 32(5): 435-438.
[1] 罗敏华, 王文平, 孔文韬. 肝脏炎性假瘤的超声造影表现及其诊断价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(03): 297-303.
[2] 贺媛媛, 李佳, 杨红. 宫颈中肾腺癌1例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(01): 97-104.
[3] 刘明禹, 马兵. 吸入性损伤早期诊断方法及策略的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 356-359.
[4] 潘兴赫, 董翔, 杨海洋, 张雪斌, 甘卫东. 超选择性前列腺动脉栓塞治疗伴急性尿潴留的高危高龄前列腺增生[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 237-242.
[5] 胡志伟, 吴继敏, 汪忠镐, 张美光. 胃食管反流病食管外症状抗反流手术适应证及术前评估[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 241-246.
[6] 廖一凡, 张松, 万宝玉, 黄文杰, 李嘉旭, 邓婕, 胡洁, 秦显莉. 18F-FDG PET/CT在肺孤立实性结节良恶性鉴别诊断中的价值分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 373-378.
[7] 白睿, 孙备. 自身免疫性胰腺炎和胰腺导管腺癌鉴别的策略与思考[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 121-126.
[8] 王素霞. IgA肾病的病理诊断与鉴别诊断[J/OL]. 中华肾病研究电子杂志, 2024, 13(02): 120-120.
[9] 戴伟川, 郭协力, 方仲宁, 蔡文华, 洪天生, 田夏阳. 显微镜下周围神经松解术治疗腰椎间盘突出症术后残余神经症状的疗效分析[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(02): 84-90.
[10] 韩俊岭, 王刚, 马厉英, 连颖, 徐慧. 维生素D 联合匹维溴铵治疗腹泻型肠易激综合征患者疗效及对肠道屏障功能指标的影响研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 560-564.
[11] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[12] 厉若男, 宋进, 王玉忠. 带状疱疹后神经痛的发病机制和诊治研究进展[J/OL]. 中华诊断学电子杂志, 2024, 12(03): 199-205.
[13] 李烽, 陈聿琦, 刘湘, 焦阳, 李晖. 假性Wellens综合征一例[J/OL]. 中华心脏与心律电子杂志, 2024, 12(01): 54-57.
[14] 贺欢, 孔文洁, 高峰. 伏诺拉生与艾司奥美拉唑治疗重度反流性食管炎的临床疗效[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(01): 6-10.
[15] 程娅雯, 韩香凝, 朱宁, 何彩莲, 张润宁, 于嘉, 韩建峰, 刘福德. 双路途指导下血管内治疗症状性非急性颈内动脉颅内段闭塞的疗效观察[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 330-337.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?